SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, DC 20549

                                   FORM 8-K

                                CURRENT REPORT
                    PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934

      Date of report (Date of earliest event reported): February 12, 2002


                              SAFLINK Corporation
            (Exact Name of Registrant as Specified in its Charter)


         Delaware                        0-20270                  95-4346070
(State or Other Jurisdiction     (Commission File Number)       (IRS Employer
     of Incorporation)                                       Identification No.)


     11911 N.E. 1/st/ Street, Suite B-304, Bellevue, Washington 98005-3032
              (Address of Principal Executive Offices) (Zip Code)


      Registrant's telephone number, including area code: (425) 278-1100


Item 5.  Other Events

     On February 15, 2002, SAFLINK Corporation ("SAFLINK") filed a motion for a
new trial on the punitive damages award and a motion for judgment
notwithstanding the verdict, in connection with a jury verdict of $150,000 in
compensatory damages and $1.5 million in punitive damages against SAFLINK in a
case brought by International Interest Group, Inc. ("IIG"). SAFLINK also filed
motions to stay entry and/or enforcement of a judgment pending the outcome of
the hearing on these motions. The motions are scheduled to be heard in
California Superior Court for the County of Los Angeles on March 14, 2002. While
a jury verdict has been rendered, a final order of the court has not yet been
entered. SAFLINK believes there are sufficient grounds to support an order for a
new trial or a judgment notwithstanding the verdict reducing or eliminating the
punitive damages award and intends to vigorously pursue its rights. There can be
no assurance that the court will rule favorably with respect to any motion filed
by SAFLINK or that SAFLINK will be successful in having the verdict set aside or
reduced.

     In January 2002, SAFLINK announced that it received funds totaling
approximately $6 million in connection with the exercise of a portion of
SAFLINK's outstanding Series A and B Warrants pursuant to its Special Warrant
Offer.

     Under the Special Warrant Offer, holders of SAFLINK's Series A and Series B
Warrants exercised warrants to purchase 5,057,732 shares of SAFLINK's common
stock at a price of $1.00 per share. The exercise price of the warrants was
reduced from $1.75 to $1.00, subject to receipt by SAFLINK of payment in full of
such warrant holders' special exercise price by the close of business on January
8, 2002. In connection with the exercise, each exercising warrant holder has
received a Series C Warrant to purchase that number of shares of SAFLINK's
common stock issued by SAFLINK to such holder upon the exercise of the original
Series A and Series B Warrants.

     On February 12, 2002, SAFLINK agreed to recast the terms of its Special
Warrant Offer for certain warrant holders, which are subject to contractual
restrictions with respect to the amount of SAFLINK common stock they may own, to
allow such holders to receive on the same terms as other offerees of the Special
Warrant Offer that number of shares of common stock that they would have
received under the Special Warrant Offer if such ownership restrictions did not
exist.

     In particular, due to a restriction in the Series A and Series B Warrants
held by SAC Capital Associates, LLC ("SAC") and SDS Merchant Fund, LP ("SDS")
which precludes each of them from exercising their respective Series A and
Series B Warrants in excess of 4.9% of SAFLINK's outstanding common stock, SAC
and SDS were unable to exercise their warrants in full but agreed to exercise a
portion of their Series A and all of their Series B warrants at a reduced price
of $1.00 per share and to purchase additional shares of common stock from
SAFLINK without exercising their warrants. Each of SAC and SDS agreed to
purchase at $1.00 per share that number of shares of SAFLINK's common stock that
SAFLINK would have issued to SAC and SDS above 4.9% if these entities were to
fully exercise their respective Series A and Series B Warrants. In connection
with their warrant exercise, each of SAC and SDS will receive a Series C Warrant
to purchase that number of shares of SAFLINK's common stock issued by SAFLINK to
such purchaser upon the exercise of the original Series A and Series B Warrants.

     The Series C Warrants have a 5 year term and are initially exercisable at
$2.25 per share, increasing to $3.50 per share six months following the
effectiveness of a registration statement (as declared by the Securities and
Exchange Commission ("SEC")) covering the shares of common stock underlying the
Series C Warrants and common stock issued to SAC and SDS.

     In connection with the transaction, SAFLINK agreed to register for resale
under the Securities Act of 1933, as amended (the "Securities Act") the common
stock underlying the Series C warrants and the common stock to be issued to SAC
and SDS, as soon as practicable after the filing of SAFLINK's Annual Report on
Form 10-K with the SEC. In addition, in connection with this transaction, each
purchaser agreed not to sell any common stock issuable

                                       2


upon conversion of its Series E Preferred Stock or upon exercise of its Series A
or Series B Warrants prior to January 12, 2002.

     In connection with the exercise of the Series A and B Warrants, the
anti-dilution provisions of the Series E Preferred Stock were waived by the
requisite majority of the holders of Series E Preferred Stock. SAFLINK is
seeking a waiver of these anti-dilution provisions in connection with the
issuance of common stock to SAC and SDS. The exercise price of the warrants held
by those holders of Series E Preferred Stock that did not elect to purchase the
shares underlying their warrants will be adjusted in accordance with the
anti-dilution provisions applicable to such warrants.

     SAFLINK intends to use the proceeds of the warrant exercises and common
stock purchases for working capital and general corporate purposes, including
repaying its short- and long-term debt. In particular, SAFLINK has applied a
portion of the proceeds received from the exercise of the Series A and Series B
Warrants to repay principal and interest payments during the one year extension
period of the $1.0 million note issued to RMS Limited Partnership, which is due
in May 2002 as required by the terms of such note extension. SAFLINK has also
applied a portion of the proceeds to repay the principal and interest payments
of the notes in aggregate principal amount of $300,000, which were issued to SDS
Merchant Fund, L.P. and Freya Fanning & Company in the December 2001 bridge
financing and were due in June 2002.

     The Series A and Series B Warrants were and the Series C Warrants and
shares of common stock will be issued pursuant to Section 4(2) and Regulation D
under the Securities Act. The Series A, Series B and Series C Warrants, the
common stock underlying the Series C Warrants, and the common stock to be issued
to SAC and SDS have not been registered under the Securities Act and may not be
offered or sold in the United States absent registration or an applicable
exemption from registration requirements.

Item 7.  Financial Statements and Exhibits

          (a)  Not applicable.

          (b)  Not applicable.

          (c)  Not applicable.

                                       3


                                  SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                     SAFLINK Corporation

Date: February 22, 2002

                                     By: /s/ Glenn Argenbright
                                         ---------------------------------------
                                         Glenn Argenbright
                                         President and Chief Executive Officer

                                       4